Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel (3T/2R). Rationale for the Study and Protocol Design.

Authors: Gianluca Campo, Nicoletta de Cesare, Pascal Vranckx, Martial Hamon, Dominick Angiolillo, Manel Sabatè, Fabrizio Ferrari, Alessandro Furgieri, Carlo Tumscitz, Alessandra Repetto, Salvatore Colangelo, Emanuele Meliga, Moh’d Kubbajeh, Giovanni Parrinello, Gianfranco Percoco

Source: Cardiovascular Drugs & Therapy; Aug2008, Vol. 22 Issue 4, p313-320, 8p